Your session is about to expire
← Back to Search
Posterior Tibial Nerve Stimulation (PTNS) for Overactive Bladder (PTNS-M Trial)
PTNS-M Trial Summary
This trial is testing whether a combination of two treatments for urinary incontinence (PTNS and mirabegron) is better than either treatment alone. The primary outcome measure is the number of urinary incontinence episodes over a 12-week treatment course.
- Overactive Bladder
PTNS-M Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Side effects data
From 2023 Phase 4 trial • 54 Patients • NCT04907032PTNS-M Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
Is Posterior Tibial Nerve Stimulation (PTNS) effective without posing any potential risks to patients?
"The team at Power assigned a score of 3 to the safety rating for Posterior Tibial Nerve Stimulation (PTNS) as it has been approved by Phase 4 trials, which are indicative of extensive efficacy and safety data."
Are any new applicants being welcomed at the moment?
"Affirmative. Evidence on clinicaltrials.gov reveals that this experiment, first advertised on October 1st 2021, is actively seeking participants. 54 individuals are needed to be sourced from one centre for the trial's successful completion."
How many participants is the clinical trial accommodating?
"Correct. The clinicaltrials.gov website confirms that this medical study, which was originally posted on October 1st 2021, is currently recruiting participants. Approximately 54 volunteers are needed to be recruited from a single research facility."
Could you provide me with a synopsis of the research conducted on Posterior Tibial Nerve Stimulation (PTNS)?
"Currently, 11 clinical studies are underway to assess the effects of Posterior Tibial Nerve Stimulation (PTNS), with 2 trials in Phase 3. There are 58 different sites across Marseille Teugbyeolsi and Seoul facilitating these research efforts."
Share this study with friends
Copy Link
Messenger